Baystate Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $30.9K | Buy |
76
+25
| +49% | +$10.2K | ﹤0.01% | 472 |
|
|
2023
Q3 | $17.7K | Sell |
51
-1
| -2% | -$348 | ﹤0.01% | 492 |
|
|
2023
Q2 | $18.3K | Buy |
52
+1
| +2% | +$352 | ﹤0.01% | 471 |
|
|
2023
Q1 | $16.1K | Sell |
51
-3
| -6% | -$945 | ﹤0.01% | 487 |
|
|
2022
Q4 | $16K | Buy |
54
+3
| +6% | +$889 | ﹤0.01% | 502 |
|
|
2022
Q3 | $15K | Sell |
51
-100
| -66% | -$29.4K | ﹤0.01% | 483 |
|
|
2022
Q2 | $43K | Hold |
151
| – | – | ﹤0.01% | 339 |
|
|
2022
Q1 | $39K | Hold |
151
| – | – | ﹤0.01% | 360 |
|
|
2021
Q4 | $33K | Hold |
151
| – | – | ﹤0.01% | 388 |
|
|
2021
Q3 | $27K | Sell |
151
-3
| -2% | -$536 | ﹤0.01% | 379 |
|
|
2021
Q2 | $31K | Hold |
154
| – | – | ﹤0.01% | 334 |
|
|
2021
Q1 | $33K | Sell |
154
-684
| -82% | -$147K | ﹤0.01% | 306 |
|
|
2020
Q4 | $198K | Buy |
838
+684
| +444% | +$162K | 0.02% | 127 |
|
|
2020
Q3 | $42K | Buy |
154
+3
| +2% | +$818 | 0.01% | 239 |
|
|
2020
Q2 | $44K | Buy |
151
+41
| +37% | +$11.9K | 0.01% | 236 |
|
|
2020
Q1 | $26K | Hold |
110
| – | – | ﹤0.01% | 256 |
|
|
2019
Q4 | $24K | Hold |
110
| – | – | ﹤0.01% | 301 |
|
|
2019
Q3 | $19K | Hold |
110
| – | – | ﹤0.01% | 299 |
|
|
2019
Q2 | $20K | Hold |
110
| – | – | ﹤0.01% | 305 |
|
|
2019
Q1 | $19K | Hold |
110
| – | – | ﹤0.01% | 313 |
|
|
2018
Q4 | $21K | Hold |
110
| – | – | ﹤0.01% | 300 |
|
|
2018
Q3 | $19K | Hold |
110
| – | – | ﹤0.01% | 309 |
|
|
2018
Q2 | $19K | Hold |
110
| – | – | ﹤0.01% | 295 |
|
|
2018
Q1 | $17K | Hold |
110
| – | – | ﹤0.01% | 305 |
|
|
2017
Q4 | $18K | Hold |
110
| – | – | ﹤0.01% | 312 |
|
|
2017
Q3 | $17K | Hold |
110
| – | – | ﹤0.01% | 300 |
|
|
2017
Q2 | $14K | Hold |
110
| – | – | ﹤0.01% | 311 |
|
|
2017
Q1 | $13K | Buy |
110
+5
| +5% | +$591 | ﹤0.01% | 317 |
|
|
2016
Q4 | $8K | Buy |
+105
| New | +$8K | ﹤0.01% | 328 |
|
|
2013
Q3 | – | Sell |
-100
| Closed | -$8K | – | 226 |
|
|
2013
Q2 | $8K | Buy |
+100
| New | +$8K | ﹤0.01% | 202 |
|